EBOS Group Ltd
NZX:EBO

Watchlist Manager
EBOS Group Ltd Logo
EBOS Group Ltd
NZX:EBO
Watchlist
Price: 38.4 NZD -0.26% Market Closed
Market Cap: 7.5B NZD
Have any thoughts about
EBOS Group Ltd?
Write Note
EBO
/
Income Statement
/
Revenue

EBOS Group Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

EBOS Group Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
EBOS Group Ltd
NZX:EBO
Revenue
AU$13.2B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
10%
Me Today Ltd
NZX:MEE
Revenue
NZ$5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

EBOS Group Ltd
Glance View

Market Cap
7.4B NZD
Industry
Health Care

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.

EBO Intrinsic Value
56.1 NZD
Undervaluation 32%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is EBOS Group Ltd's Revenue?
Revenue
13.2B AUD

Based on the financial report for Jun 30, 2024, EBOS Group Ltd's Revenue amounts to 13.2B AUD.

What is EBOS Group Ltd's Revenue growth rate?
Revenue CAGR 10Y
10%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for EBOS Group Ltd have been 13% over the past three years , 14% over the past five years , and 10% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 204,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.